000			02077 a2200625 4500
005			20250516214133.0
264		0	_c20141003
008			201410s 0 0 eng d
022			_a1532-1827
024	7		_a10.1038/bjc.2014.251 _2doi
040			_aNLM _beng _cNLM
100	1		_aNishio, H
245	0	0	_aImmunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor. _h[electronic resource]
260			_bBritish journal of cancer _cJun 2014
300			_a2965-74 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdoptive Transfer
650	0	4	_aAnimals
650	0	4	_aArginase _xblood
650	0	4	_aBenzamides _xpharmacology
650	0	4	_aCarcinoma, Ovarian Epithelial
650	0	4	_aCell Line, Tumor
650	0	4	_aCulture Media, Conditioned _xpharmacology
650	0	4	_aCyclohexanones _xpharmacology
650	0	4	_aDendritic Cells _ximmunology
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmune Tolerance
650	0	4	_aInterleukin-6 _xbiosynthesis
650	0	4	_aInterleukin-8 _xbiosynthesis
650	0	4	_aMacrophages _ximmunology
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Nude
650	0	4	_aNeoplasm Transplantation
650	0	4	_aNeoplasms, Glandular and Epithelial _ximmunology
650	0	4	_aOvarian Neoplasms _ximmunology
650	0	4	_aSignal Transduction _ximmunology
650	0	4	_aTranscription Factor RelA _xantagonists & inhibitors
650	0	4	_aTransplantation, Heterologous
700	1		_aYaguchi, T
700	1		_aSugiyama, J
700	1		_aSumimoto, H
700	1		_aUmezawa, K
700	1		_aIwata, T
700	1		_aSusumu, N
700	1		_aFujii, T
700	1		_aKawamura, N
700	1		_aKobayashi, A
700	1		_aPark, J
700	1		_aAoki, D
700	1		_aKawakami, Y
773	0		_tBritish journal of cancer _gvol. 110 _gno. 12 _gp. 2965-74
856	4	0	_uhttps://doi.org/10.1038/bjc.2014.251 _zAvailable from publisher's website
999			_c23861899 _d23861899